<DOC>
	<DOCNO>NCT02099162</DOCNO>
	<brief_summary>Optical coherence tomography ( OCT ) recently study evaluation coronary stenting . Because high resolution , several report show OCT appropriate evaluate neointimal tissue coronary stent implantation . Also , strut coverage characterization neointimal tissue accurately evaluate . Furthermore , OCT-defined coverage stent strut propose related clinical safety drug-eluting stents-treated patient . Therefore , evaluate appropriateness currently use coronary stent ( e.g . Sirolimus elute stent , Paclitaxel-eluting stent , Zotarolimus-eluting stent , Everolimus-eluting stent , Biolimus elute stent , EPC ( endothelial progenitor cell ) Capture stent , etc ) base finding OCT. Additionally , evaluate neointimal hyperplasia , malposition strut coverage decide difference stent characteristic , duration antiplatelet use , difference accord clinical presentation .</brief_summary>
	<brief_title>Yonsei OCT ( Optical Coherence Tomography ) Registry Evaluation Efficacy Safety Coronary Stenting</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>1 . Patients coronary stent 2 . Patients coronary stent coronary artery stenosis 1 . Hemodynamically unstable patient 2 . Ostial lesion begin within 15 mm leave main coronary artery 3 . Lesions diameter 4 mm 4 . Patients allergy antiplatelet agent ( asprin clopidogrel ) 5 . Patients hepatic dysfunction ( Liver enzyme 3 time upper limit normal ) 6 . Pregnant lactate patient 7 . Patients life expectancy le 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>OCT</keyword>
	<keyword>Coronary</keyword>
	<keyword>Stenting</keyword>
</DOC>